Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease
Faculty Advisor
Kara SmithDocument Type
Journal ArticlePublication Date
2020-10-27Keywords
Cognitive impairmentParkinson’s disease
Parkinson’s progression markers initiative
subjective cognitive decline
Metadata
Show full item recordAbstract
We investigated patient and clinician impressions of cognitive impairment and whether they correlated with objective measures of cognitive impairment. Cognitive categorization, neuropsychological assessment scores, and Montreal Cognitive Assessment scores were documented at baseline, 3 years, and 7 years for 388 PD patients in the Parkinson's Progression Markers Initiative (PPMI). We found that both patient and clinician impressions of cognitive decline were significantly associated with gold-standard criteria for cognitive impairment to a similar degree. Both patient and clinician perspectives should be considered in determining cognitive status and should be followed up with diagnostic testing.Source
Ngo AB, Smith KM. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1695-1698. doi: 10.3233/JPD-202110. PMID: 32925096; PMCID: PMC7814400.DOI
10.3233/JPD-202110Permanent Link to this Item
http://hdl.handle.net/20.500.14038/51236PubMed ID
32925096Notes
Angeline Ngo participated in this study as a medical student in the Senior Scholars research program at the University of Massachusetts Medical School.ae974a485f413a2113503eed53cd6c53
10.3233/JPD-202110